Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue

Fatigue is the most common symptom of MS and has no effective pharmacotherapy. To determine the tolerability, safety, and efficacy of low-dose ketamine infusion for MS-related fatigue. In this double-blind, randomized, active-placebo-controlled trial, 18 subjects with multiple sclerosis (MS) and rep...

Full description

Bibliographic Details

Published in:	Multiple sclerosis Vol. 27; no. 6; p. 942
Main Authors:	Fitzgerald, Kathryn C, Morris, Bridget, Soroosh, Aurash, Balshi, Alexandra, Maher, Dermot, Kaplin, Adam, Nourbakhsh, Bardia
Format:	Journal Article
Language:	English
Published:	England 01.05.2021
Subjects:	Double-Blind Method Fatigue - drug therapy Fatigue - etiology Humans Ketamine - adverse effects Multiple Sclerosis - complications Multiple Sclerosis - drug therapy Pilot Projects Treatment Outcome Multiple sclerosis fatigue ketamine midazolam randomized controlled trial
ISSN:	1477-0970, 1477-0970
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!